The Role of Panobinostat Plus Bortezomib and Dexamethasone in Treating Relapsed or Relapsed and Refractory Multiple Myeloma: A European Perspective

Overview of attention for article published in Advances in Therapy, September 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 1 X users, with an upper bound of 1,222 followers.

Panobinostat + bortezomib & dexamethasone in treating relapsed or relapsed & refractory multiple myeloma https://t.co/eOowcctDKG #cancer https://t.co/mO3N9WuBMU

Reply Repost Favourite

Panobinostat + bortezomib & dexamethasone in treating relapsed or relapsed & refractory multiple myeloma https://t.co/eOowcctDKG #cancer

Reply Repost Favourite

Role of #Panobinostat + #Bortezomib & #Dexamethasone in Treating Relapsed or Relapsed & Refractory #MultipleMyeloma https://t.co/eOowcctDKG

Reply Repost Favourite